Temporal Dynamics of Cortical Microinfarcts in Cerebral Small Vessel Disease

Annemieke Ter Telgte1, Kim Wiegertjes1, Benno Gesierich2

  • 1Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Radboud University Medical Center, Nijmegen, the Netherlands.

JAMA Neurology
|February 18, 2020
PubMed
Abstract

Insights

Newly detected acute cortical microinfarcts (A-CMI) are often invisible on follow-up MRI scans and may explain the high prevalence of these lesions found in neuropathology studies of aging brains.

Area of Science:

  • Neurology
  • Neuroradiology
  • Cerebrovascular Disease

Background:

  • Cortical microinfarcts (CMIs) are common in aging brains, particularly in patients with cerebrovascular disease and dementia.
  • Most CMIs are not visible on standard MRI, creating a diagnostic challenge.
  • Acute CMIs (A-CMI) may be detectable in their early stages, but their temporal dynamics are poorly understood.

Purpose of the Study:

  • To investigate the prevalence and temporal dynamics of A-CMI in individuals with cerebral small vessel disease (SVD).
  • To determine if A-CMI evolve into chronic lesions detectable by MRI.

Main Methods:

  • A prospective cohort study (RUN DMC-Intense) involving 54 participants with SVD.
  • Monthly 3-T MRI scans, including high-resolution diffusion-weighted imaging (DWI), were acquired over a median of 39.5 weeks.
  • Statistical analysis was performed to assess CMI incidence and temporal changes.

Main Results:

  • The prevalence of chronic CMIs (C-CMI) was 35%.
  • A cumulative incidence of 13% for A-CMI was detected via monthly DWI scans in 7 participants.
  • All detected A-CMI resolved completely on subsequent MRI scans.

Conclusions:

  • Acute CMIs detected by DWI in SVD patients are transient and do not evolve into chronically visible lesions on MRI.
  • These transient A-CMI likely represent a significant portion of the submillimeter CMIs observed in neuropathological studies.
  • The findings help explain the discrepancy between MRI-detected and neuropathologically confirmed CMI burden.